Evaluating Bone Forming agents on Bone Mineral Density in Vitamin D Deficiency: A Prospective Observational Study in a Rural Tertiary Care Setting

Vitamin D deficiency is one of the major public health concern due to its detrimental impact on bone health, particularly in rural settings with limited healthcare resources. Vitamin D is crucial for the absorption of calcium and metabolic function in bone, and its deficiency can lead to increased osteoclastic activity, lower bone mineral density (BMD), and higher fracture risks. This study investigates the effectiveness of various bone-forming agents in improving BMD among individuals with vitamin D deficiency in a rural tertiary care setting.

To evaluate the impact of different bone-forming agents on BMD and vitamin D deficiency in a rural population and identify the most effective treatment modality.

A prospective observational study was conducted over six months at Dhiraj Hospital, Vadodara, Gujarat, India. A total of 102 participants with vitamin D deficiency, aged 18 or older, were enrolled and divided into three treatment groups: Zoledonate injection (Group 1), Ibandronate tablet (Group 2), and Calcitonin nasal spray (Group 3). BMD was assessed using bone densitometer scans at baseline and three months post-treatment. The T-score was categorized as Normal, Osteopenia, or Osteoporosis. Data were analyzed using Microsoft Excel.

Out of the 102 participants, 60(58.82%) were osteoporotic and 42(41.18%) were osteopenic at baseline. After treatment, osteoporosis decreased significantly from 60 to 15, while osteopenia increased from 42 to 85, with 2 showing normal BMD. Zoledonate and Ibandronate demonstrated the greatest improvement in BMD, with the largest effect sizes, while Calcitonin showed a modest improvement. Gender-specific and age-related differences in treatment outcomes were noted, with a substantial overall enhancement in BMD following treatment.

Zoledonate and Ibandronate were more effective than Calcitonin nasal spray in improving BMD among patients with vitamin D deficiency. This study underscores the importance of targeted treatment strategies for bone health in rural populations. Future research should further explore these interventions' long-term benefits and applicability in similar settings.